Privia Health
PRVA
231 hedge funds and large institutions have $2.35B invested in Privia Health in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 102 increasing their positions, 64 reducing their positions, and 30 closing their positions.
198% more call options, than puts
Call options by funds: $7.97M | Put options by funds: $2.68M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
59% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 64
8% more capital invested
Capital invested by funds: $2.18B → $2.35B (+$168M)
0.08% less ownership
Funds ownership: 100.15% → 100.07% (-0.08%)
1% less funds holding
Funds holding: 234 → 231 (-3)
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$19M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$9.97M |
| 3 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$7.5M |
| 4 |
Goldman Sachs
New York
|
+$6.46M |
| 5 |
BlackRock
New York
|
+$5.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$32.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$32.1M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$8.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.31M |
| 5 |
Bank of New York Mellon
New York
|
-$4.51M |
PRVA Hedge Fund Activity: Q4 2024 in Review
231 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Privia Health (PRVA) for Q4 2024, worth a combined $2.35B — up 7.7% from $2.18B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PRVA and 27 opened new positions — a net loss of 3 holders — while 64 trimmed existing stakes and 102 added.
The largest buyer was Riverbridge Partners, adding an estimated $19M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $32.9M.
- 231 institutional investors held Privia Health (PRVA) as of Q4 2024, down from 234 in Q3 2024.
- Funds reported $2.35B of Privia Health stock for Q4 2024, up 7.7% quarter-over-quarter.
- 27 funds opened new Privia Health positions in Q4 2024 and 30 closed out, a net change of -3 holders.
- The largest Privia Health buyer in Q4 2024 was Riverbridge Partners, an estimated $19M added.
- The largest Privia Health seller in Q4 2024 was T. Rowe Price Investment Management, an estimated $32.9M sold.
Based on aggregated 13F filings for Q4 2024.